We are so proud to see Dr. Hans Hammers’s clinical trial of RADVAX selected for presentation at ASCO GU 2020. ASCO is the American Society of Clinical Oncology, and ASCO GU focuses on genitourinary cancers.

RADVAX combines SBRT with immunotherapy. This clinical trial showed that high-dose radiation added to immunotherapy can help more patients respond to immunotherapy. Using SBRT to inflame tumors can help the immune system recognize the tumor and therefore increases the response rate to immunotherapy. Higher response rates show that radiation is helping turn some people whose cancer would not respond to immunotherapy (non-responders) into responders.

The encouraging results for kidney cancer patients from this preliminary trial led to the selection of Dr. Hans Hammers and RADVAX for a presentation at ASCO.  

This trial was 100% patient and community funded through the grassroots efforts of Ralph and Brenda Knapp and KidneyCAN.

After impressive response rates, Bristol Myers Squibb has funded this SBRT and immunotherapy combination for continued research, which we hope to see translate quickly to clinical use. Ralph was one of the first patients to receive RADVAX and is pictured here with his wife Brenda and Dr. Hammers. 

Ralph and Brenda Knapp with Dr. Hans Hammers

You can check out Dr. Hammers’s ASCO GU abstract here, but do follow us on Facebook and Twitter to see our live updates of the event this week!

 

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORY BOARD →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Dr. John T. Wilson: “A Lot of Reason to Hope”

Dr. John T. Wilson: “A Lot of Reason to Hope”

Researcher Spotlight: Dr. John T. Wilson Giving Patients "A Lot of Reason to Hope" At KidneyCAN, we have the pleasure of meeting and working with talented researchers from all over the world. We want to share some of the insights and experiences of one such researcher today, Dr. John T. Wilson,...

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DISTRICT DAYS →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Dr. John T. Wilson: “A Lot of Reason to Hope”

Dr. John T. Wilson: “A Lot of Reason to Hope”

Researcher Spotlight: Dr. John T. Wilson Giving Patients "A Lot of Reason to Hope" At KidneyCAN, we have the pleasure of meeting and working with talented researchers from all over the world. We want to share some of the insights and experiences of one such researcher today, Dr. John T. Wilson,...

FACING KIDNEY CANCER →

DIAGNOSIS →

BUILDING A CARE TEAM →

LEARN ABOUT CLINICAL TRIALS →

LIVING WELL WITH KIDNEY CANCER →

DONATE →

CONTACT →

Latest News

World Kidney Cancer Day 2021: We Need to Talk About How We’re Feeling

World Kidney Cancer Day 2021: We Need to Talk About How We’re Feeling

On June 17th, people from all around the world came together to participate in activities for #WorldKidneyCancerDay, and we’re proud to share what KidneyCAN did in partnership with the IKCC and many other partners from the kidney cancer community. Our goal each year on World Kidney Cancer Day is...

KCRS →

RESEARCH OPPORTUNITIES →

ADVOCATE WITH KIDNEYCAN →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Dr. John T. Wilson: “A Lot of Reason to Hope”

Dr. John T. Wilson: “A Lot of Reason to Hope”

Researcher Spotlight: Dr. John T. Wilson Giving Patients "A Lot of Reason to Hope" At KidneyCAN, we have the pleasure of meeting and working with talented researchers from all over the world. We want to share some of the insights and experiences of one such researcher today, Dr. John T. Wilson,...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

World Kidney Cancer Day 2021: We Need to Talk About How We’re Feeling

World Kidney Cancer Day 2021: We Need to Talk About How We’re Feeling

On June 17th, people from all around the world came together to participate in activities for #WorldKidneyCancerDay, and we’re proud to share what KidneyCAN did in partnership with the IKCC and many other partners from the kidney cancer community. Our goal each year on World Kidney Cancer Day is...